Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (611) 611
humans (586) 586
life sciences & biomedicine (584) 584
topotecan (499) 499
oncology (440) 440
female (389) 389
biological and medical sciences (346) 346
medical sciences (345) 345
topotecan - administration & dosage (308) 308
pharmacology. drug treatments (296) 296
antineoplastic agents (295) 295
chemotherapy (295) 295
male (288) 288
topotecan - pharmacokinetics (270) 270
adult (219) 219
middle aged (216) 216
aged (202) 202
animals (201) 201
antineoplastic agents - pharmacokinetics (199) 199
pharmacology & pharmacy (180) 180
antineoplastic combined chemotherapy protocols - therapeutic use (151) 151
topotecan - adverse effects (151) 151
topotecan - therapeutic use (145) 145
cancer (142) 142
antineoplastic agents - administration & dosage (140) 140
antineoplastic agents - therapeutic use (136) 136
camptothecin - analogs & derivatives (132) 132
neoplasms - drug therapy (131) 131
tumors (129) 129
mice (122) 122
drug administration schedule (115) 115
pharmacokinetics (115) 115
dose-response relationship, drug (104) 104
topotecan - pharmacology (104) 104
treatment outcome (98) 98
antineoplastic agents - adverse effects (97) 97
child (89) 89
infusions, intravenous (84) 84
ovarian neoplasms - drug therapy (84) 84
antineoplastic agents - pharmacology (81) 81
adolescent (80) 80
medicine & public health (78) 78
antineoplastic combined chemotherapy protocols - adverse effects (77) 77
child, preschool (77) 77
topoisomerase i inhibitors (77) 77
camptothecin - pharmacokinetics (74) 74
cell line, tumor (72) 72
lung neoplasms - drug therapy (72) 72
administration, oral (71) 71
antineoplastic combined chemotherapy protocols - administration & dosage (63) 63
care and treatment (63) 63
ovarian cancer (62) 62
drug resistance, neoplasm (61) 61
toxicity (61) 61
pharmacology/toxicology (58) 58
research (57) 57
irinotecan (55) 55
camptothecin - therapeutic use (54) 54
antineoplastic combined chemotherapy protocols - pharmacokinetics (52) 52
area under curve (52) 52
camptothecin (52) 52
neoplasm recurrence, local - drug therapy (51) 51
antimitotic agents (50) 50
hematology (50) 50
analysis (48) 48
drug therapy (48) 48
maximum tolerated dose (48) 48
physical sciences (48) 48
camptothecin - administration & dosage (47) 47
camptothecin - pharmacology (47) 47
chemistry (47) 47
atp binding cassette transporter, sub-family g, member 2 (46) 46
neoplasms - metabolism (46) 46
infant (45) 45
pediatrics (43) 43
topotecan - blood (42) 42
brain neoplasms - drug therapy (41) 41
clinical trials (41) 41
survival rate (41) 41
pharmacology (39) 39
rats (39) 39
cancer therapies (38) 38
carboplatin (37) 37
carcinoma, small cell - drug therapy (37) 37
endocrine system diseases (37) 37
carboplatin - administration & dosage (36) 36
neutropenia - chemically induced (36) 36
camptothecin - adverse effects (35) 35
mice, nude (35) 35
topoisomerase i inhibitors - administration & dosage (35) 35
aged, 80 and over (34) 34
cisplatin (34) 34
cisplatin - administration & dosage (34) 34
tumor cells, cultured (34) 34
lung cancer (33) 33
drug resistance (32) 32
etoposide - administration & dosage (32) 32
liposomes (32) 32
models, biological (32) 32
neuroblastoma (32) 32
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Pharmacology of Anticancer Drugs in the Elderly Population
by Wildiers H and Highley M.S and de Bruijn E.A and van Oosterom A.T
2003, Volume 42, Issue 14, 30
Melphalan, pharmacokinetics | Vinblastine, pharmacokinetics | Cytarabine, pharmacokinetics | Antimetabolites, pharmacokinetics | Gemcitabine, pharmacodynamics | Vinca alkaloids, pharmacodynamics | Fluorouracil, pharmacokinetics | Ifosfamide, pharmacodynamics | Methotrexate, pharmacokinetics | Topotecan, pharmacodynamics | Capecitabine, pharmacodynamics | Irinotecan, pharmacokinetics | Vinca alkaloids, pharmacokinetics | Alkylating agents, pharmacokinetics | Chlorambucil, pharmacokinetics | Cyclophosphamide, pharmacodynamics | Vincristine, pharmacokinetics | Carboplatin, pharmacodynamics | Fludarabine, pharmacodynamics | Cisplatin, pharmacokinetics | Vinorelbine, pharmacodynamics | Capecitabine, pharmacokinetics | Platinum complexes, pharmacokinetics | Topotecan, pharmacokinetics | Cytarabine, pharmacodynamics | DNA topoisomerase inhibitors, pharmacodynamics | Chlorambucil, pharmacodynamics | Fluorouracil, pharmacodynamics | Fludarabine, pharmacokinetics | Cyclophosphamide, pharmacokinetics | Antimetabolites, pharmacodynamics | Gemcitabine, pharmacokinetics | Melphalan, pharmacodynamics | Oxaliplatin, pharmacokinetics | Vinblastine, pharmacodynamics | Vinorelbine, pharmacokinetics | Cisplatin, pharmacodynamics | Vincristine, pharmacodynamics | Oxaliplatin, pharmacodynamics | Irinotecan, pharmacodynamics | Ifosfamide, pharmacokinetics | Methotrexate, pharmacodynamics | Alkylating agents, pharmacodynamics | Platinum complexes, pharmacodynamics | Carboplatin, pharmacokinetics | Elderly | DNA topoisomerase inhibitors, pharmacokinetics | Cancer | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Chemotherapy | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Drug Interactions | Antineoplastic Agents - adverse effects | Humans | Aged, 80 and over | Aging | Aged | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Frail Elderly | Patient Compliance | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Index Medicus
Book Review
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Pharmacokinetically Guided Administration of Chemotherapeutic Agents
by van den Bongard H.J.G.D and Mathot R.A.A and Beijnen J.H and Schellens J.H.M
11/2000, Volume 39, Issue 5, 23
NSC 95580, pharmacokinetics | Teniposide, pharmacokinetics | Topotecan, pharmacokinetics | Iododoxorubicin, pharmacokinetics | Fluorouracil, pharmacokinetics | Cyclophosphamide, pharmacokinetics | Menogaril, pharmacokinetics | Research and development | Paclitaxel, pharmacokinetics | Epirubicin, pharmacokinetics | Etoposide, pharmacokinetics | Antineoplastics, pharmacokinetics | Busulfan, pharmacokinetics | Docetaxel, pharmacokinetics | Idarubicin, pharmacokinetics | Carboplatin, pharmacokinetics | Cisplatin, pharmacokinetics | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Chemotherapy | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Busulfan - pharmacokinetics | Cisplatin - pharmacokinetics | Area Under Curve | Humans | Carboplatin - administration & dosage | Etoposide - administration & dosage | Carboplatin - pharmacokinetics | Antineoplastic Agents - administration & dosage | Busulfan - administration & dosage | Cisplatin - administration & dosage | Animals | Fluorouracil - administration & dosage | Topotecan - pharmacokinetics | Topotecan - administration & dosage | Antineoplastic Agents - pharmacokinetics | Fluorouracil - pharmacokinetics | Etoposide - pharmacokinetics | Index Medicus
Book Review
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Anti-cancer drug delivery using metal organic frameworks (MOFs)
by Ibrahim, Mihad and Sabouni, Rana and Husseini, Ghaleb A
Current medicinal chemistry, ISSN 0929-8673, 01/2017, Volume 24, Issue 2, pp. 193 - 214
Cytotoxicity | Chemotherapy | Metal organic frameworks (MOFs) | Loading | Release | Cancer | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Humans | Succinates - pharmacokinetics | Antineoplastic Agents - administration & dosage | Busulfan - administration & dosage | Organoplatinum Compounds - pharmacology | Drug Carriers | Nanoparticles | Fluorouracil - administration & dosage | Organoplatinum Compounds - pharmacokinetics | Camptothecin - administration & dosage | Antineoplastic Agents - pharmacokinetics | Doxorubicin - administration & dosage | Camptothecin - pharmacokinetics | Busulfan - pharmacokinetics | Polymers - chemical synthesis | Doxorubicin - pharmacokinetics | Organometallic Compounds - chemical synthesis | Topotecan - pharmacokinetics | Cell Line, Tumor | Topotecan - administration & dosage | Organometallic Compounds - chemistry | Polymers - chemistry | Porosity | Fluorouracil - pharmacokinetics | Succinates - pharmacology | Drug carriers | Drug delivery systems | 5-Fluorouracil | Biodegradability | Metals | Polyelectrolytes | Drug delivery | Doxorubicin | Biomedical materials | Catalysis | Methotrexate | Polymers | Metal ions | Biodegradation | Medical imaging | Pharmacology | Tamoxifen | Cisplatin | Side effects | In vivo methods and tests | Liposomes | Pharmacokinetics | Metal-organic frameworks
Journal Article
Details down arrow
4. Full Text The Effect of Low pH on Breast Cancer Resistance Protein (ABCG2)-Mediated Transport of Methotrexate, 7-Hydroxymethotrexate, Methotrexate Diglutamate, Folic Acid, Mitoxantrone, Topotecan, and Resveratrol in In Vitro Drug Transport Models
by Pauline Breedveld and Dick Pluim and Greta Cipriani and Femke Dahlhaus and Maria A. J. van Eijndhoven and Cornelia J. F. de Wolf and Annemieke Kuil and Jos H. Beijnen and George L. Scheffer and Gerrit Jansen and Piet Borst and Jan H. M. Schellens
Molecular pharmacology, ISSN 0026-895X, 01/2007, Volume 71, Issue 1, pp. 240 - 9
ATP Binding Cassette Transporter, Subfamily G, Member 2 | Cell Line | Rabbits | Humans | ATP-Binding Cassette Transporters/metabolism | Topotecan/pharmacokinetics | Mitoxantrone/pharmacokinetics | Animals | Antineoplastic Agents/pharmacokinetics | Biological Transport | Stilbenes/pharmacokinetics | Folic Acid/pharmacokinetics | Liver/metabolism | Dogs | Resveratrol | Cell Line, Tumor | Methotrexate/analogs & derivatives | Female | Kinetics | Neoplasm Proteins/metabolism | Breast Neoplasms/metabolism | Hydrogen-Ion Concentration | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Liver - metabolism | Methotrexate - pharmacokinetics | Neoplasm Proteins - metabolism | Folic Acid - pharmacokinetics | Breast Neoplasms - metabolism | Topotecan - pharmacokinetics | ATP-Binding Cassette Transporters - metabolism | Stilbenes - pharmacokinetics | Antineoplastic Agents - pharmacokinetics | Mitoxantrone - pharmacokinetics | Methotrexate - analogs & derivatives | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Pharmacokinetics Following Intraventricular Administration of Chemotherapy in Patients with Neoplastic Meningitis
by Gudrun Fleischhack and Ulrich Jaehde and Udo Bode
2005, Volume 44, Issue 1, 31
Mafosfamide, pharmacokinetics | Cytarabine, pharmacokinetics | Topotecan, pharmacokinetics | Diaziquone, pharmacokinetics | Methotrexate, pharmacokinetics | Research and development | Corticosteroids, pharmacokinetics | Etoposide, pharmacokinetics | Antineoplastics, pharmacokinetics | Bleomycin, pharmacokinetics | Nimustine, pharmacokinetics | Mercaptopurine, pharmacokinetics | Meningitis, treatment | Thiotepa, pharmacokinetics | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Biological and medical sciences | Chemotherapy | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Injections, Spinal | Infusion Pumps, Implantable | Drug Administration Schedule | Humans | Injections, Intraventricular | Metabolic Clearance Rate | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Animals | Meningeal Neoplasms - cerebrospinal fluid | Meningeal Neoplasms - drug therapy | Cerebrospinal Fluid - metabolism | Adolescent | Adult | Antineoplastic Agents - pharmacokinetics | Child | Meningeal Neoplasms - secondary | Index Medicus
Book Review
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children’s Oncology Group phase 1 consortium study (ADVL1212)
by Greengard, Emily and Mosse, Yael P and Liu, Xiaowei and Minard, Charles G and Reid, Joel M and Voss, Stephan and Wilner, Keith and Fox, Elizabeth and Balis, Frank and Blaney, Susan M and Adamson, Peter C and Weigel, Brenda J
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 12/2020, Volume 86, Issue 6, pp. 829 - 840
Crizotinib | Oncology | Phase 1 | Pediatric | Chemotherapy combinations | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Pediatrics | Toxicity | Cytotoxicity | Topotecan | Pharmacology | Exposure | Bioavailability | Doxorubicin | Vincristine | Lymphoma | Patients | Consortia | Microspheres | Cyclophosphamide | Chemotherapy | Palatability | Anaplastic large-cell lymphoma | Children | Safety | Solid tumors | Pharmacokinetics | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Camptothecin and podophyllotoxin derivatives: Inhibitors of topoisomerase I and II - Mechanisms of action, pharmacokinetics and toxicity profile
by Hartmann, J̈org T and Lipp, Hans-Peter
Drug safety, ISSN 0114-5916, 2006, Volume 29, Issue 3, pp. 209 - 230
Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Toxicology | Life Sciences & Biomedicine | Science & Technology | Camptothecin - adverse effects | Podophyllotoxin - pharmacology | Camptothecin - therapeutic use | Podophyllotoxin - adverse effects | Humans | Enzyme Inhibitors - pharmacology | Podophyllotoxin - therapeutic use | Topoisomerase I Inhibitors | Neoplasms - enzymology | Enzyme Inhibitors - therapeutic use | Neoplasms - drug therapy | Topoisomerase II Inhibitors | Antineoplastic Agents, Phytogenic - pharmacology | Antineoplastic Agents, Phytogenic - therapeutic use | Camptothecin - pharmacology | Antineoplastic Agents, Phytogenic - adverse effects | Index Medicus
Journal Article
Details down arrow